(Q37151964)

18 August 2017

1 reference

title

Are we poised to target ACE2 for the next generation of antihypertensives? (English)

1 reference

18 August 2017

Anderson J Ferreira

1

1 reference

18 August 2017

Mohan K Raizada

series ordinal

2

1 reference

18 August 2017

publication date

1 May 2008

1 reference

Journal of Molecular Medicine

18 August 2017

published in

1 reference

18 August 2017

volume

86

1 reference

18 August 2017

issue

6

1 reference

18 August 2017

page(s)

685-690

1 reference

https://scigraph.springernature.com/pub.10.1007/s00109-008-0339-x

18 August 2017

exact match

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS00109-008-0339-X

Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00109-008-0339-X

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00109-008-0339-X

Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats.

21 January 2018

1 reference

12 December 2020

ACE2 overexpression inhibits hypoxia-induced collagen production by cardiac fibroblasts.

1 reference

12 December 2020

Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents.

1 reference

12 December 2020

Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ischemia-induced pathophysiology

1 reference

12 December 2020

ACE2 gene expression is up-regulated in the human failing heart

1 reference

12 December 2020

Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II.

1 reference

12 December 2020

Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes.

1 reference

12 December 2020

Developmental expression of ACE2 in the SHR kidney: a role in hypertension?

1 reference

12 December 2020

Novel drugs targeting hypertension: renin inhibitors

1 reference

12 December 2020

Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme

1 reference

12 December 2020

Angiotensin-converting enzyme 2 (ACE2), but not ACE, is preferentially localized to the apical surface of polarized kidney cells

1 reference

12 December 2020

Angiotensin-(1-7) and its receptor as a potential targets for new cardiovascular drugs

1 reference

12 December 2020

The endothelium-dependent vasodilator effect of the nonpeptide Ang(1-7) mimic AVE 0991 is abolished in the aorta of mas-knockout mice.

1 reference

12 December 2020

The emerging role of ACE2 in physiology and disease

1 reference

12 December 2020

ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR.

1 reference

12 December 2020

Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice.

1 reference

12 December 2020

Study of angiotensin-(1-7) vasoactive peptide and its beta-cyclodextrin inclusion complexes: complete sequence-specific NMR assignments and structural studies

1 reference

12 December 2020

Angiotensin-converting enzyme 2 and angiotensin-(1-7): an evolving story in cardiovascular regulation.

1 reference

12 December 2020

Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats

1 reference

12 December 2020

ACE2: a new target for cardiovascular disease therapeutics

1 reference

12 December 2020

Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase

1 reference

12 December 2020

Role of the pressor action of angiotensin II in experimental hypertension.

1 reference

12 December 2020

The discovery and development of angiotensin II antagonists

1 reference

12 December 2020

Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas

1 reference

12 December 2020

Myocardial infarction increases ACE2 expression in rat and humans.

1 reference

12 December 2020

Nonpeptide AVE 0991 is an angiotensin-(1-7) receptor Mas agonist in the mouse kidney.

1 reference

12 December 2020

Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy.

1 reference

12 December 2020

Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism

1 reference

12 December 2020

Short-term angiotensin(1-7) receptor MAS stimulation improves endothelial function in normotensive rats

1 reference

12 December 2020

A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase

1 reference

12 December 2020

ACE and ACE2 activity in diabetic mice.

1 reference

12 December 2020

ACE2 of the heart: From angiotensin I to angiotensin (1-7)

1 reference

12 December 2020

Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat

1 reference

12 December 2020

Renal ACE2 expression in human kidney disease

1 reference

12 December 2020

ACE2: A novel therapeutic target for cardiovascular diseases

1 reference

12 December 2020

The difficult conception, birth and delivery of a renin inhibitor: controversies around aliskiren

1 reference

12 December 2020

Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme Homologue ACE2.

1 reference

12 December 2020

Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination?

1 reference

12 December 2020

AVE 0991, a nonpeptide mimic of the effects of angiotensin-(1-7) on the endothelium.

1 reference

12 December 2020

The nonpeptide angiotensin-(1-7) receptor Mas agonist AVE-0991 attenuates heart failure induced by myocardial infarction

1 reference

12 December 2020

Antihypertensive therapy with aliskiren

1 reference

12 December 2020

ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice.

1 reference

12 December 2020

Effect of angiotensin-(1-7) on reperfusion arrhythmias in isolated rat hearts

1 reference

12 December 2020

Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis

1 reference

12 December 2020

Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II

1 reference

12 December 2020

Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats

1 reference

12 December 2020

Angiotensin-converting enzyme 2 is an essential regulator of heart function

1 reference

12 December 2020

The role of angiotensin converting enzyme 2 in the generation of angiotensin 1-7 by rat proximal tubules

1 reference

12 December 2020

Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors

1 reference

12 December 2020

Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins

1 reference

12 December 2020

Angiotensin-(1-7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME

1 reference

12 December 2020

Beneficial versus harmful effects of Angiotensin (1-7) on impulse propagation and cardiac arrhythmias in the failing heart

1 reference

12 December 2020

Structure-based design of aliskiren, a novel orally effective renin inhibitor

1 reference

12 December 2020

Isoproterenol-induced impairment of heart function and remodeling are attenuated by the nonpeptide angiotensin-(1-7) analogue AVE 0991

1 reference

12 December 2020

10.1007/S00109-008-0339-X

Identifiers

DOI

1 reference

18 August 2017

1 reference